White matter synapses: Form, function, and dysfunction

Neurology

Volumn 76, Issue 4, 2011, Pages 397-404

  Alix, James J P ^a,c   De Jesus Domingues, António Miguel ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BEPRIDIL; CHLORPHENIRAMINE MALEATE PLUS PHENYLEPHRINE; MEMANTINE; NITRENDIPINE; PERAMPANEL; PREGABALIN; TOPIRAMATE;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; ARTICLE; CELL FUNCTION; DEGENERATIVE DISEASE; GLIA CELL; HUMAN; HUNTINGTON CHOREA; MULTIPLE SCLEROSIS; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; STROKE; SYNAPSE; SYNAPTIC TRANSMISSION; WHITE MATTER;

EID: 79251550472     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182088273     Document Type: Review

References (60)

1. Gottlieb M, Matute C. Expression of ionotropic glutamate receptor subunits in glial cells of the hippocampal CA1 area following transient forebrain ischemia. J Cereb Blood Flow Metab 1997;17:290-300.
2. Bergles DE, Roberts JD, Somogyi P, Jahr CE. Glutamater-gic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 2000;405:187-191.
3. Micu I, Jiang Q, Coderre E, et al. NMDA receptors mediate calcium accumulation in myelin during chemical isch-aemia. Nature 2006;439:988-992.
4. Salter MG, Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005;438:1167-1171.
5. Karadottir R, Cavelier P, Bergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005;438:1162-1166.
6. Lisman JE, Raghavachari S, Tsien RW. The sequence of events that underlie quantal transmission at central gluta-matergic synapses. Nat Rev Neurosci 2007;8:597-609.
7. Back SA, Craig A, Kayton RJ, et al. Hypoxia-ischemia preferentially triggers glutamate depletion from oligoden-droglia and axons in perinatal cerebral white matter. J Cereb Blood Flow Metab 2006;27:334-347.
8. Kriegler S, Chiu SY. Calcium signaling of glial cells along mammalian axons. J Neurosci 1993;13:4229-4245.
9. Kukley M, Capetillo-Zarate E, Dietrich D. Vesicular glu-tamate release from axons in white matter. Nature Neuroscience 2007;10:311-320.
10. Alix JJ, Dolphin AC, Fern R. Vesicular apparatus, including functional calcium channels, are present in developing rodent optic nerve axons and are required for normal node of Ranvier formation. J Physiol 2008;586:4069-4089.
11. Protti DA, Reisin R, Mackinley TA, Uchitel OD. Calcium channel blockers and transmitter release at the normal human neuromuscular junction. Neurology 1996;46:1391-1396.
12. Hamilton N, Vayro S, Wigley R, Butt AM. Axons and astrocytes release ATP and glutamate to evoke calcium signals in NG2-glia. Glia 2010;58:66-79.
13. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE. Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 2007;10:321-330.
14. Etxeberria A, Mangin J-M, Aguirre A, Gallo V. Adult-born SVZ progenitors receive transient synapses during re-myelination in corpus callosum. Nat Neurosci 2010;13: 287-289.
15. De Biase LM, Nishiyama A, Bergles DE. Excitability and synaptic communication within the oligodendrocyte lineage. J Neurosci 2010;30:3600-3611.
16. Staugaitis SM, Trapp BD. NG2-positive glia in the human central nervous system. Neuron Glia Biol 2009:1-10.
17. Hamilton N, Hubbard PS, Butt AM. Effects of glutamate receptor activation on NG2-glia in the rat optic nerve. J Anat 2009;214:208-218.
18. Zhu X, Bergles DE, Nishiyama A. NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development 2008;135:145-157.
19. Wang C, Pralong WF, Schulz MF, et al. Functional N-methyl-D-aspartate receptors in O-2A glial precursor cells: a critical role in regulating polysialic acid-neural cell adhesion molecule expression and cell migration. J Cell Biol 1996;135:1565-1581.
20. Gyllensten L, Malmfors T, Norrlin-Grettve ML. Visual and non-visual factors in the centripetal stimulation of postnatal growth of the visual centers in mice. J Comp Neurol 1967;131:549-557.
21. Ishibashi T, Dakin KA, Stevens B, et al. Astrocytes promote myelination in response to electrical impulses. Neuron 2006;49:823-832.
22. Stevens B, Porta S, Haak LL, Gallo V, Fields RD. Adeno-sine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron 2002; 36:855-868.
23. Bengtsson SL, Nagy Z, Skare S, Forsman L, Forssberg H, Ullen F. Extensive piano practicing has regionally specific effects on white matter development. Nat Neurosci 2005; 8:1148-1150.
24. Scholz J, Klein MC, Behrens TE, Johansen-Berg H. Training induces changes in white-matter architecture. Nat Neurosci 2009;12:1370-1371.
25. Fields RD. Oligodendrocytes changing the rules: action potentials in glia and oligodendrocytes controlling action potentials. Neuroscientist 2008;14:540-543.
26. Alix JJ, Fern R. Glutamate receptor-mediated ischemic injury of premyelinated central axons. Ann Neurol 2009;66: 682-693.
27. Haynes RL, Billiards SS, Borenstein NS, Volpe JJ, Kinney HC. Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin. Pediatr Res 2008;63:656-661.
28. Bakiri Y, Hamilton NB, Karadottir R, Attwell D. Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter. Glia 2008;56: 233-240.
29. Follett PL, Deng W, Dai W, et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 2004;24:4412-4420.
30. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 2000;20:9235-9241.
31. Zhang K, Sejnowski TJ. A universal scaling law between gray matter and white matter of cerebral cortex. Proc Natl Acad Sci USA 2000;97:5621-5626.
32. Ihara M, Polvikoski TM, Hall R, et al. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol 2010;119:579-589.
33. Fern R, Ransom BR, Waxman SG. Voltage-gated calcium channels in CNS white matter: role in anoxic injury. J Neurophysiol 1995;74:369-377.
34. Ouardouz M, Nikolaeva MA, Coderre E, et al. Depolarization-induced Ca2+ release in ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryanodine receptors. Neuron 2003;40:53-63.
35. Ouardouz M, Coderre E, Basak A, et al. Glutamate receptors on myelinated spinal cord axons: I: GluR6 kainate receptors. Ann Neurol 2009;65:151-159.
36. Ouardouz M, Malek S, Coderre E, Stys PK. Complex interplay between glutamate receptors and intracellular Ca2+ stores during ischaemia in rat spinal cord white matter. J Physiol 2006;577:191-204.
37. Tekkok SB, Goldberg MP. AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 2001;21:4237-4248.
38. Ouardouz M, Coderre E, Zamponi GW, et al. Glutamate receptors on myelinated spinal cord axons: II: AMPA and GluR5 receptors. Ann Neurol 2009;65:160-166.
39. Lipton SA. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov 2006;5:160-170.
40. Craner MJ, Newcombe J, Black JA, Hartle C, Cuzner ML, Waxman SG. Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. Proc Natl Acad Sci USA 2004;101:8168-8173.
41. Alix JJ. Axons and multiple sclerosis. Mult Scler 2009;15: 278.
42. Kornek B, Storch MK, Bauer J, et al. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 2001;124:1114-1124.
43. Trapp BD, Stys PK. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 2009;8:280-291.
44. Chang A, Tourtellotte WW, Rudick R, Trapp BD. Pre-myelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002;346:165-173.
45. Brand-Schieber E, Werner P. Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis. Exp Neurol 2004;189:5-9.
46. Smith T, Groom A, Zhu B, Tukski L. Autoimmune en-cephalomyelitis ameliorated by AMPA antagonists. Nat Med 2000;6:62-66.
47. Villoslada P, Arrondo G, Sepulcre J, Alegre M, Artieda J. Memantine induces reversible neurologic impairment in patients with MS. Neurology 2009;72:1630-1633.
48. Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 2004;25:5-18.
49. Desai MK, Sudol KL, Janelsins MC, Mastrangelo MA, Frazer ME, Bowers WJ. Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia 2009;57:54-65.
50. Ogawa Y, Rasband MN. The functional organization and assembly of the axon initial segment. Curr Opin Neuro-biol 2008;18:307-313.
51. Schmidt R, Ropele S, Pendl B, et al. Longitudinal multi-modal imaging in mild to moderate Alzheimer disease: a pilot study with memantine. J Neurol Neurosurg Psychiatry 2008;79:1312-1317.
52. Sapp E, Schwarz C, Chase K, et al. Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol 1997;42:604-612.
53. Fennema-Notestine C, Archibald SL, Jacobson MW, et al. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 2004;63: 989-995.
54. Li H, Wyman T, Yu Z-X, Li S-H, Li X-J. Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release. Hum Mol Genet 2003;12:2021-2030.
55. Gunawardena S, Her L-S, Brusch RG, et al. Disruption of axonal transport by loss of huntingtin or expression of pathogenic PolyQ proteins in Drosophila. Neuron 2003; 40:25-40.
56. Bossy-Wetzel E, Petrilli A, Knott AB. Mutant huntingtin and mitochondrial dysfunction. Trends Neurosci 2008; 31:609-616.
57. Davis KL, Stewart DG, Friedman JI, et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 2003;60:443-456.
58. Foong J, Maier M, Clark CA, Barker GJ, Miller DH, Ron MA. Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Psychiatry 2000;68:242-244.
59. Schmidt-Kastner R, Van Os J, Steinbusch HWM, Schmitz C. Gene regulation by hypoxia and the neurodevelopmen-tal origin of schizophrenia. Schizophr Res 2006;84:253-271.
60. Talbot K, Eidem WL, Tinsley CL, et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hip-pocampal formation in schizophrenia. J Clin Invest 2004; 113:1353-1363.